Delivery Order SPE2DE21D0007-SPE2D623F1NU8

Award Date 7/11/23
Potential Completion Date 8/1/23
Potential Value $916
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Ortho-Clinical Diagnostics Inc. was awarded a $5,543.20 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Troop Support Medical (DLA) to provide 4561371436 units of ANTI-A BIOCLONE 15X10ML. The place of performance will be in Raritan, New Jersey, with work scheduled to be completed by July 3, 2023 under a start date of June 28, 2023. As a component of the Department of Defense, DLA supports America's armed forces by procuring and providing logistics...
Ortho-Clinical Diagnostics Inc. was awarded a $916 fixed-price delivery order with economic price adjustment against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical. The delivery order, issued on August 7, 2023, is for the procurement of 4561733234 ANTI-A BIOCLONE 15X10ML, with a period of performance concluding on August 28, 2023. No set-aside provisions were applied to this award. Place of performance will be in Raritan, New Jersey. As...
Ortho-Clinical Diagnostics Inc. was awarded a $916.27 fixed-price delivery order with economic price adjustment against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. The prime contractor will provide 4561553107 Anti-A Biocloone to the agency in 15 vials of 10 milliliters each. Performance will take place at Ortho-Clinical Diagnostics' facility in Raritan, New Jersey, with work expected to conclude by August 10, 2023. No subcontractors or...
Ortho-Clinical Diagnostics Inc. has been awarded a $2,650.70 fixed-price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. The prime contractor will provide 15 boxes containing 10 milliliters each of an anti-A bioclone product to the Defense Logistics Agency by August 4, 2023. Performance will take place at Ortho-Clinical Diagnostics' facility in Raritan, New Jersey. No subcontractors or set-aside designations were...
Ortho-Clinical Diagnostics Inc. has been awarded a $1,132.50 fixed-price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract vehicle. The prime contractor will provide 4561925559 Anti-A Bioclome 3x10ml to the Defense Logistics Agency, the logistics combat support agency within the U.S. Department of Defense, by August 25, 2023 from its facility in Raritan, New Jersey. No subcontractors or set-aside designations were...
Ortho-Clinical Diagnostics Inc. was awarded a $916 fixed-price delivery order with economic price adjustment against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical. The September 23, 2023 award is for the delivery of 15 boxes containing 10 milliliters each of an unspecified anti-A biologic product by September 27, 2023. The place of performance is in Raritan, New Jersey. No set-aside provisions were applied to this order to supply...
Ortho-Clinical Diagnostics Inc. was awarded a $916 fixed-price delivery order with economic price adjustment against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical. The delivery order (Contract #4561974865) is for 15 boxes containing 10 milliliters each of an unspecified anti-A biologic product. Performance will occur in Raritan, New Jersey with all work required to be completed by September 19, 2023. No set-aside provisions were...
Ortho-Clinical Diagnostics Inc. was awarded a $916 fixed-price delivery order with economic price adjustment against an unidentified government-wide acquisition contract vehicle. The contract calls for the delivery of 15 boxes containing 10 milliliters each of ANTI-B BIOCLONE to the Defense Logistics Agency Troop Support Medical facility in Raritan, New Jersey, with all work to be completed by August 11, 2023. No set-aside provisions were applied to this award to supply medical products in...
Ortho-Clinical Diagnostics Inc. was awarded a $4,581 fixed price delivery order against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical to provide 15 boxes containing 10 milliliters each of an anti-B bioclone product. Place of performance will be the prime contractor's facility located in Raritan, New Jersey. The delivery order has a period of performance from July 20, 2023 through July 25, 2023 and utilizes fixed pricing with economic...
Ortho-Clinical Diagnostics Inc. has been awarded a $916 fixed price delivery order against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical to provide 15 boxes containing 10 milliliters each of an unspecified anti-A biologic product. Performance will occur in Raritan, New Jersey by September 6, 2023. No set-aside provisions were applied to this award to supply unspecified medical products in support of the Defense Logistics Agency Troop...
  • SPE2DE21D0007
    Indefinite Delivery Contract
  • SPE2DE21D0007-SPE2D623F1NU8
    Delivery Order

Ortho-Clinical Diagnostics Inc. was awarded a $916.27 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Troop Support Medical (DLA) to provide 4561462367 anti-A bioclomes in 15x10ml packages. Place of performance will be the prime contractor's facility located in Raritan, New Jersey. The order is associated with DLA's medical supply support to the Department of Defense and has a period of performance starting July 11, 2023 through August 1, 2023. No set-aside designation or subcontractors were identified in the award information.

Generated 12/17/23, 10:13 PM